What is the Ownership and Shareholding Structure of Systopic Pharmaceuticals?
In 2017, Systopic Pharmaceuticals had a promoter holding of 83.32% and a public holding of 16.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX